Julia Wang

Julia Wang joined BeiGene in June 2020 and currently serves as Chief Financial Officer. In this role, she partners across the enterprise to optimize intrinsic value creation through greater financial discipline. Ms. Wang has extensive global finance experience across biotech, pharmaceutical, medical devices, diagnostic testing, and consumer products. She was most recently Senior Vice President, Global Business Finance, Corporate Finance and Corporate FP&A at Alexion Pharmaceuticals, and prior to that position she served in various leadership roles at Quest Diagnostics. Previously, Ms. Wang spent over five years at Johnson & Johnson leading finance at several operating companies, including Xian-Janssen Pharmaceutical, J&J’s pharmaceutical business in China. She received an MBA from Fuqua School of Business at Duke University and a B.A. in British Language and Literature from Shandong Normal University.